An aptamer/liposome (A/Lipo) complex with an affinity for HCC was used to deliver small interference RNA targeting YTHDF2 (A/Lipo/si‐YTHDF2) to the livers of the orthotopic HCC model (Figure 7B).[37] The dispersity of A/Lipo/si‐YTHDF2 (Figure S10A, Supporting Information) and its knockdown efficiency (Figure 7C) were confirmed. The gene discussed is YTHDF2; the disease is hepatocellular carcinoma.